Home/Filings/4/0001209191-20-004966
4//SEC Filing

Levy Howard 4

Accession 0001209191-20-004966

CIK 0001124105other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 2:00 PM ET

Size

5.4 KB

Accession

0001209191-20-004966

Insider Transaction Report

Form 4
Period: 2020-01-23
Levy Howard
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-23+45,00045,000 total
    Exercise: $6.85Exp: 2030-01-23Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]Award vests over a four (4) year period on each monthly anniversary commencing January 23, 2020.

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001672333

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 2:00 PM ET
Size
5.4 KB